-
The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells.
EMBO J. 2007 Oct 3;26(19):4252-62
PMID: 17853891
-
Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma.
Lancet. 2003 Jan 18;361(9353):217-23
PMID: 12547545
-
Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Blood. 1995 Jul 15;86(2):659-65
PMID: 7605996
-
The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis.
Blood. 2008 Feb 15;111(4):2280-9
PMID: 18042799
-
Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
Nat Med. 2002 Oct;8(10):1098-104
PMID: 12219084
-
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
Hematology Am Soc Hematol Educ Program. 2007;:277-84
PMID: 18024641
-
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.
Mol Cell. 2005 Feb 4;17(3):393-403
PMID: 15694340
-
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3260-5
PMID: 10737792
-
Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation.
Cancer Cell. 2004 Dec;6(6):577-86
PMID: 15607962
-
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.
Blood. 2010 Feb 4;115(5):925-35
PMID: 19880495
-
Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma.
J Infect Dis. 1996 Mar;173(3):529-35
PMID: 8627013
-
Posttransplantation lymphoproliferative disorders.
Arch Intern Med. 2003 Sep 22;163(17):1997-2004
PMID: 14504111
-
Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes.
J Virol. 1994 May;68(5):3410-4
PMID: 8151802
-
Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.
EMBO J. 1999 Oct 1;18(19):5321-33
PMID: 10508165
-
Action of Myc in vivo - proliferation and apoptosis.
Curr Opin Genet Dev. 2000 Feb;10(1):100-5
PMID: 10679391
-
Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen.
Science. 1996 Sep 6;273(5280):1384-6
PMID: 8703072
-
The ornithine decarboxylase gene is a transcriptional target of c-Myc.
Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7804-8
PMID: 8356088
-
Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
Oncogene. 2008 Jan 17;27(4):421-33
PMID: 17653091
-
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.
Immunity. 2000 Oct;13(4):497-506
PMID: 11070168
-
Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14269-74
PMID: 14603034
-
Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.
J Virol. 1994 Sep;68(9):6069-73
PMID: 8057484
-
The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim.
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5663-8
PMID: 19293378
-
Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice.
Science. 1995 Mar 10;267(5203):1506-10
PMID: 7878471
-
The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines.
Virology. 2009 Apr 10;386(2):387-97
PMID: 19217135
-
Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
EMBO J. 1998 Mar 16;17(6):1700-9
PMID: 9501091
-
The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells.
Plasmid. 2007 Jul;58(1):1-12
PMID: 17350094
-
Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus.
J Virol. 1997 Mar;71(3):1766-75
PMID: 9032305
-
Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue.
Blood. 1998 Feb 15;91(4):1373-81
PMID: 9454768
-
The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency.
J Virol. 2008 Jun;82(12):5693-702
PMID: 18385243
-
Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14188-93
PMID: 16966603
-
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12616-21
PMID: 9356498
-
B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2.
EMBO J. 1995 Jan 3;14(1):88-96
PMID: 7828599
-
Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.
Proc Natl Acad Sci U S A. 1982 Dec;79(24):7837-41
PMID: 6818551
-
Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing.
Immunity. 1997 Dec;7(6):791-802
PMID: 9430224
-
Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.
Blood. 2008 Dec 1;112(12):4384-99
PMID: 19029456
-
Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell.
J Virol. 1997 Jul;71(7):4882-91
PMID: 9188550
-
Programmed cell death: alive and well in the new millennium.
Trends Cell Biol. 2001 Dec;11(12):526-34
PMID: 11719060
-
Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.
J Virol. 2005 Aug;79(16):10709-17
PMID: 16051863
-
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
J Virol. 1994 Nov;68(11):7374-85
PMID: 7933121
-
Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13022-7
PMID: 20615947
-
Mechanisms of tamoxifen resistance.
Endocr Relat Cancer. 2004 Dec;11(4):643-58
PMID: 15613444
-
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy.
Leukemia. 2002 Nov;16(11):2190-6
PMID: 12399961
-
Transfer of a functional human immune system to mice with severe combined immunodeficiency.
Nature. 1988 Sep 15;335(6187):256-9
PMID: 2970594
-
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
PLoS Pathog. 2009 Mar;5(3):e1000341
PMID: 19283066
-
Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.
Oncogene. 2007 Feb 26;26(9):1297-305
PMID: 17322915
-
Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
EMBO J. 1987 Sep;6(9):2743-51
PMID: 2824192
-
Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Oncogene. 1996 Feb 1;12(3):621-9
PMID: 8637719
-
Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.
EMBO J. 1996 Dec 16;15(24):7070-8
PMID: 9003782